Jasper Therapeutics (JSPR) Total Debt (2022)
Jasper Therapeutics (JSPR) posted quarterly Total Debt of $18000.0 for Q4 2022.
Jasper Therapeutics (JSPR) Total Debt (2022) Analysis & Trends
Jasper Therapeutics' Total Debt history runs 1 years deep, the most recent figure standing at $18000.0 for Q4 2022.
- In Q4 2022, Total Debt changed N/A year-over-year to $18000.0; the TTM figure through Dec 2022 stood at $18000.0 (changed N/A YoY), while the FY2022 annual figure was $18000.0, changed N/A from the prior year.
- Total Debt for Q4 2022 stood at $18000.0.
- The five-year high for Total Debt was $18000.0 in Q4 2022, with the low at $18000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | - |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | 9.34 Bn |
| 10 | Jasper Therapeutics | 20.30 Mn | 20.30 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 18,000.00 |